Loading
Menu
  • Home
  • Physician Education Center
    • Enduring Programs
      • Acute Heart Failure
      • Alzheimer’s Disease
      • Biosimilars
      • COPD
      • Multiple Sclerosis
      • Oncology Pathways
      • PD-1 Inhibition
      • Prostate Cancer
      • Rheumatology
      • Schizophrenia
    • Close
  • Pharma Education Center
    • Enduring Clinical Programs
      • Acute Heart Failure
      • Alzheimer’s Disease
      • Ankylosing Spondylitis
      • Asthma
      • Chronic Kidney Disease
      • COPD
      • Crohn’s Disease
      • Epilepsy
      • Familial Hypercholesterolemia
      • Hemophilia
      • Hepatitis
      • HIV/AIDS
      • Immunoglobulins
      • Multiple Sclerosis
      • Pulmonary Arterial Hypertension
      • Rheumatoid Arthritis
      • Schizophrenia
      • Transplantation
    • Enduring Oncology Programs
      • Acute Lymphoblastic Leukemia
      • Acute Myeloid Leukemia
      • Glioblastoma Multiforme
      • Head and Neck Cancer
      • Lung Cancer
      • Multiple Myeloma
      • Oncology Pathways
      • Oral Oncolytics
      • PD-1 Inhibition
      • Prostate Cancer
    • Enduring Business Programs
      • Biosimilars
    • CPE Webinars
      • Biosimilars
    • CPE Print/Monographs
    • Close
  • About SPEC
    • Get Involved
    • Accreditations
    • Terms of Use
    • FAQs
    • Close
  • My Learning Activities
  • Login/Register

Quality Pharmacy Education

The Specialty Pharma Education Center (SPEC) prides itself in being the leader and the biggest proponent of specialty education amongst pharmacists and in the pharmaceutical industry. With nearly 200 hours of continuing pharmacy education (CPE), SPEC continues to grow and add more CPE for you.

All Specialty Pharma Education Center’s CE are also accredited for Nurses CNE by the American Nurses Credentialing Center (ANCC).

Click Here to View your Account and Activities on SPEC

VIEW MY LEARNING ACTIVITIES

New CPE Courses added

  • Hepatitis C

    An Update in the Treatment and Management of HCV in Special Populations (2.0 hours)

  • Crohn’s Disease

    Crohn’s Disease: Clinical Considerations for the Healthcare Professional (1.5 hours)

  • Asthma

    Advances in Severe Asthma: Clinical Phenotypes, Biomarkers and Biologics (1.0 Hour)

  • Lung Cancer

    The Basic Building Blocks: An Overview of Lung Cancer (1.5 Hours)

  • HIV/AIDS

    Antiretroviral Therapy: Updated Guidelines & Strategies for Treatment and Management of HIV (1.5 Hours)

Coming Soon!

  • Lung Cancer

    Incorporating Value into Lung Cancer Management: A Review of Contemporary Care Issues (1.5 hours)

  • Lung Cancer

    Targeted Therapies for Non-Small Cell Lung Cancer: Considerations for the Collaborative Healthcare Team (2.0 hours)

  • Multiple Myeloma

    Novel and Emerging Agents: Targeted Therapies in Multiple Myeloma (1.5 Hours)

  • Hemophilia

    Managing Inhibitors in Hemophilia Patients (2.0 Hours)

View Full Catalog
View CPE Requirements by your State or Country

View SPEC’s Newsletter Archive

Sign up for the SPEC Monthly Newsletter

1 + 0 = ?

Sign Up for our Monthly Newsletter!

Latest Published CME/CPE/CNE

An Overview of Pulmonary Arterial Hypertension (PAH): Update on Clinical Considerations & Diagnosis

Ankylosing Spondylitis: An Update on Clinical Considerations, Diagnosis and Treatment Options

Individualized Treatment Plans in ALL: Effective Management Strategies to Optimize Patient Outcomes

The Growing Threat of HPV-Positive Head and Neck Cancer

RA: Prevention and Management of Toxicities Associated with Disease Modifying Therapies

Upcoming Events

  • No events

Contact Us

Specialty Pharma Education Center
 703.229.6260
 info@specialtycme.org

© Copyright 2017 - Specialty Pharma Education Center. All Rights Reserved.

Scroll to top